Berger Joel, Wagner John A
Department of Metabolic Disorders-Diabetes, Merck Research Laboratories, PO Box 2000, Rahway, New Jersey 07065, USA.
Diabetes Technol Ther. 2002;4(2):163-74. doi: 10.1089/15209150260007381.
The peroxisome proliferator-activated receptors (PPARs) are a group of nuclear receptor isoforms, including PPARgamma, PPARalpha, and PPARdelta, encoded by different genes. PPARs are ligand-regulated transcription factors that control gene expression by binding to specific response elements (PPREs) within promoters. PPARs bind as heterodimers with a retinoid X receptor and, upon binding agonist, interact with cofactors increasing the rate of transcription initiation. The PPARs play a critical physiological role as lipid sensors and regulators of lipid metabolism. Natural ligands for the PPARs include fatty acids and eicosanoids. More potent synthetic PPAR ligands, including the fibrates and thiazolidinediones, are effective in the treatment of dyslipidemia and diabetes. Use of selective ligands led to the discovery of additional potential roles for the PPARs in pathological states, including atherosclerosis, inflammation, and hypertension. This review provides an overview of the molecular mechanisms of PPAR action and the involvement of the PPARs in the etiology and treatment of several chronic diseases.
过氧化物酶体增殖物激活受体(PPARs)是一组核受体亚型,包括由不同基因编码的PPARγ、PPARα和PPARδ。PPARs是配体调节的转录因子,通过与启动子内的特定反应元件(PPREs)结合来控制基因表达。PPARs与视黄酸X受体形成异二聚体结合,在结合激动剂后,与辅助因子相互作用,增加转录起始速率。PPARs作为脂质传感器和脂质代谢调节剂发挥着关键的生理作用。PPARs的天然配体包括脂肪酸和类花生酸。更有效的合成PPAR配体,包括贝特类药物和噻唑烷二酮类药物,在治疗血脂异常和糖尿病方面有效。使用选择性配体导致发现了PPARs在病理状态下的其他潜在作用,包括动脉粥样硬化、炎症和高血压。本综述概述了PPAR作用的分子机制以及PPARs在几种慢性疾病的病因学和治疗中的参与情况。